NOTE: By submitting this form and registering with us, you are providing us with permission to store your personal data and the record of your registration. In addition, registration with Irish Pharmacist includes granting consent for the delivery of that additional professional content and targeted ads, and the cookies required to deliver same. View our Privacy Policy and Cookie Notice for further details.

ADVERTISMENT

ADVERTISMENT

Scientists discover potential new method to treat superbug infections

By Irish Pharmacist - 30th Jan 2023

superbug infections

Scientists at University of Galway have detailed a new discovery with the potential to improve treatment options for superbug MRSA infections with penicillin-type antibiotics that have become ineffective on their own.

The research has been published in the flagship journal of the American Society for Microbiology, mBio.

Prof James P O’Gara and Dr Merve S Zeden in the School of Biological and Chemical Sciences, University of Galway, led the study.

Prof O’Gara said: “This discovery is important because it has revealed a potentially new way to treat MRSA infections with penicillin-type drugs, which remain the safest and most
effective antibiotics.”

The antimicrobial resistance (AMR) crisis is one of the greatest threats to human health, with superbugs like MRSA placing a significant burden on global healthcare resources. 

The microbiology research team at University of Galway showed that MRSA could be much more efficiently killed by penicillin-type antibiotics when combined with purines, which are the building
blocks for DNA. 

Dr Zeden said: “Purine nucleosides, Adenosine, Xanthosine, Guanosine, are sugar versions of the building blocks of DNA, and our work showed that they interfere with signalling systems in the bacterial cell, which are required for antibiotic resistance.”

This study was recently highlighted in the American Society for Microbiology’s This Week in Microbiology podcast.

The discussion noted the drugs derived from purines are already used to treat some viral infections and cancers.

Aaron Nolan is a PhD student at University of Galway and was co-first author on the paper. He said: “Finding new ways to re-sensitise superbugs to currently-licenced antibiotics is a crucial part of efforts to tackle the AMR crisis. Our research implicated the potential of purine nucleosides in re-sensitising MRSA to penicillin-type antibiotics.” 

This research, which was funded by the Health Research Board, Science Foundation Ireland and the Irish Research Council, was conducted in collaboration with scientists at Imperial College London and the University of Sheffield.

ADVERTISMENT

Latest

ADVERTISMENT

ADVERTISMENT

ADVERTISMENT

Latest Issue

Irish Pharmacist July 2024

Irish Pharmacist July 2024

Irish Pharmacist July 2024. Volume 25 | Issue 7 | July 2024. Read the latest issue of Irish Pharmacist here…

Read

OTC Update Spring 2024

Spring 2024 | Issue 1 | Volume 18. Read the latest issue of OTC Update here.

Read

ADVERTISMENT

ADVERTISMENT

ADVERTISMENT

ADVERTISMENT